ChemAbout

ChemAbout is a B2B platform where chemical buyers and suppliers discover each other.

Post a purchase requestList your products (for suppliers)
© 2026 ChemAbout
Compound Index|Demand Board|Insights|Exhibitions|Compliance|Help Center|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/Research Reagent/D-Phe-L-pipecolyl-Arg-p-nitroanilide dihydrochloride
C27H36N8O5
552.6 g/mol
Research ReagentWarning

D-Phe-L-pipecolyl-Arg-p-nitroanilide dihydrochloride

CAS115388-96-0EC634-224-0
Category
Research Reagent
Compound Class
Peptide
Primary Use
Research Compound

This compound is a chromogenic thrombin substrate used in laboratory research. It consists of a tripeptide sequence D-Phe-pipecolyl-Arg linked to a p-nitroanilide group, which releases a colored product upon enzymatic cleavage.

chromogenic substrate for thrombin activity assaysresearch reagent for protease studies

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing D-Phe-L-pipecolyl-Arg-p-nitroanilide dihydrochloride?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→

Related Compounds

ReferenceSame Category

2,6-Dibromo-9,10-bis(9,9-dimethyl-9H-fluoren-2-yl)-9,10-dihydroanthracene-9,10-diol

CAS1154751-56-0

research compound

ReferenceSame Category

N-phenyl-1-(phenylmethyl)-4-piperidinamine

CAS1155-56-2

research compound

ReferenceSame Category

N-Cbz-L-glutamic acid

CAS1155-62-0

research compound

ReferenceSame Category

(1R,2S)-rel-2-(3,4-Difluorophenyl)cyclopropanamine hydrochloride

CAS1156491-10-9

research compound

Related Reading

Therapeutic Peptides in 2026: This Year's Breakthroughs

2026 has been a concentrated year for peptide therapeutics. Efficacy reached a new high in late-stage trials, the obesity field moved beyond the incretins to amylin, the oral route reached weight management, and peptide-guided radioligand therapy kept advancing — each point tied to a specific 2025–2026 result.

Read more

Safety Reference

Harmful
Harmful
Health Hazard
Health Hazard
Warning
H302Harmful if swallowed
H312Harmful in contact with skin
H315Causes skin irritation
H319Causes serious eye irritation
H332Harmful if inhaled
H335May cause respiratory irritation
H361Suspected of damaging fertility or the unborn child
Identifiers
IUPAC Name

1-[(2R)-2-amino-3-phenylpropanoyl]-N-[(2S)-5-(diaminomethylideneamino)-1-(4-nitroanilino)-1-oxopentan-2-yl]piperidine-2-carboxamide

InChIKey

YDMBNDUHUNWWRP-AXWGZAFASA-N

SMILES

C1CCN(C(C1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NC2=CC=C(C=C2)[N+](=O)[O-])C(=O)[C@@H](CC3=CC=CC=C3)N

Synonyms (7)
  • D-Phe-Pip-Arg-PNA
  • S-2238(Thrombin Substrate)

Sourcing D-Phe-L-pipecolyl-Arg-p-nitroanilide dihydrochloride?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→